Biogen (NASDAQ:BIIB) reported its Q3 earnings results on Tuesday, October 25, 2022 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Biogen beat estimated earnings by 14.66%, reporting an EPS of $4.77 versus an estimate of $4.16.
Revenue was down $270.50 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.15 which was followed by a 3.17% increase in the share price the next day.
Here’s a look at Biogen’s past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 4.10 | 4.38 | 3.40 | 4.11 |
| EPS Actual | 5.25 | 3.62 | 3.39 | 4.77 |
| Revenue Estimate | 2.48B | 2.49B | 2.62B | 2.67B |
| Revenue Actual | 2.59B | 2.53B | 2.73B | 2.78B |
To track all earnings releases for Biogen visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
